Increased Th17 Cell Frequency and Poor Clinical Outcome in Rheumatoid Arthritis Are Associated With a Genetic Variant in the IL4R Gene, rs1805010
Open Access
- 8 January 2014
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatology
- Vol. 66 (5) , 1165-1175
Abstract
Objective: The minor allele of the IL4R gene single‐nucleotide polymorphism, rs1805010, confers impaired interleukin‐4 (IL‐4) signaling and has been associated with an aggressive destructive course of rheumatoid arthritis (RA). IL‐4 inhibits the development of Th17 cells, a cell population recently identified as being prominent in RA patients and being associated with cartilage and bone destruction. The purpose of the present study was to investigate whether rs1805010 modulates Th17 cell development and, hence, subsequent clinical outcome in RA.Methods: A total of 90 patients with early, active RA (mean ± SD Disease Activity Score in 28 joints 4.6 ± 1.1) and 39 control subjects (24 healthy subjects and 15 patients with osteoarthritis [OA]) were genotyped. Serum levels of IL‐17 and IL‐22 as well as frequencies of Th17 cells were analyzed by enzyme‐linked immunosorbent assay and flow cytometry. Clinical and radiographic data were collected and evaluated at baseline and 1 year after disease onset.Results: Twenty‐six percent of the RA patients were homozygous for the major allele of rs1805010, 60% were heterozygous, and 14% were homozygous for the minor allele. The RA patients who were homozygous for the minor allele demonstrated significantly higher clinical activity associated with the presence of erosions after 1 year of followup as compared to the other RA patients. The inhibitory effect of IL‐4 on Th17 cell development in these patients was significantly less prominent. Accordingly, the frequencies of Th17 cells and serum levels of IL‐17 and IL‐22 were significantly increased.Conclusion: The data indicate that the rs1805010 minor allele contributes to increased Th17 cell frequency, enhanced clinical activity, and accelerated radiographic progression in RA by rendering CD4 T cells from RA patients insensitive to the attenuating effect of IL‐4 on Th17 cell development.Keywords
This publication has 33 references indexed in Scilit:
- Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial diseaseHuman Molecular Genetics, 2012
- Polymorphism in the vascular endothelial growth factor A (VEGFA) gene is associated with serum VEGF-A level and disease activity in rheumatoid arthritis: Differential effect of cigarette smokingCytokine, 2012
- Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2011
- A polymorphism in the interleukin-4 receptor affects the ability of interleukin-4 to regulate Th17 cells: a possible immunoregulatory mechanism for genetic control of the severity of rheumatoid arthritisArthritis Research & Therapy, 2011
- Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritisArthritis & Rheumatism, 2009
- GATA‐3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritisArthritis & Rheumatism, 2009
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationJournal of Experimental Medicine, 2005
- IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesisJournal of Clinical Investigation, 1999
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988